|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 401/04 | (2013.01) | ||
| A61K 31/4545 | (2006.01) |
| (11) | Patento numeris | 3853217 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19862150.0 |
| Europos patento paraiškos padavimo data | 2019-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2019/106433 |
| Data | 2019-09-18 |
| (87) | Numeris | WO 2020/057549 |
| Data | 2020-03-26 |
| (30) | Numeris | Data | Šalis |
| 201862732994 P | 2018-09-18 | US |
| (72) |
CHEN, Xiangyang , CN
WANG, Zuopeng , CN
YU, Liqin , CN
|
| (73) |
Beijing InnoCare Pharma Tech Co., Ltd. ,
Bldg. 8, Community No. 1
No. 8 Courtyard, Life Park Road
ZGC Life Science Park
Changping District, Beijing 102206,
CN
|
| (54) | CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |
| CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |